BlackRock Fund Advisors’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14K Buy
157
+27
+21% +$2.42K ﹤0.01% 3930
2016
Q3
$14K Buy
130
+13
+11% +$1.01K ﹤0.01% 3921
2016
Q2
$7K Buy
117
+9
+8% +$621 ﹤0.01% 4044
2016
Q1
$8K Buy
108
+23
+27% +$1.73K ﹤0.01% 4017
2015
Q4
$8K Buy
+85
New +$7.21K ﹤0.01% 4054

Other funds holding VNRX

BlackRock Fund Advisors's VNRX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its VolitionRx Ltd (VNRX) stake by 21% in Q4 2016, buying an estimated $2.42K and bringing the position to 157 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3930.

BlackRock Fund Advisors first reported a position in VNRX in Q4 2015 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold VNRX as of Q4 2016.

  • BlackRock Fund Advisors held 157 shares of VolitionRx Ltd worth $14K as of Q4 2016.
  • BlackRock Fund Advisors bought 27 VolitionRx Ltd shares in Q4 2016, an estimated $2.42K.
  • VolitionRx Ltd made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3930 holding.
  • BlackRock Fund Advisors first reported a position in VolitionRx Ltd in Q4 2015 and has held it in 5 quarters since.
  • 17 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.